Primary Record
Piboserod
Note: Only for scientific research or as raw materials for production.
- In stock
- 1,757 g
- Purity
- 98.2 %
- CAS
- 152811-62-6
Compound Identifiers & Properties
- CAS
- 152811-62-6
- PubChem CID
- 177336
- SMILES
- CCCCN1CCC(CC1)CNC(=O)C2=C3N(CCCO3)C4=CC=CC=C42
- Canonical SMILES
- CCCCN1CCC(CNC(=O)c2c3n(c4ccccc24)CCCO3)CC1
Names & Synonyms
- Piboserod
- piboserodum
- 152811-62-6
- Piboserod?
- Piboserod [INN]
- 5 HT4 Antagonist
- 5-HT4 Antagonist
- 5 HT4 Antagonists
- 5-HT4 Antagonists
- Piboserod [INN:BAN]
- Antagonist, 5-HT4
- Piboserod hydrochloride
- Antagonists, 5-HT4
- SB-207266
- PIBOSEROD [MI]
- RefChem:174124
- D0X2XF
- SB207266(Piboserod)
- UNII-4UQ3S81B25
- AC1L42OO
- PIBOSEROD [WHO-DD]
- 4UQ3S81B25
- GTPL225
- SCHEMBL467339
- DTXSID60165129
- MFCD00923681
- CHEMBL356359
- orb1305814
- Serotonin 5-HT4 Receptor Antagonists
- DTXCID8087620
- SB207256
- SCHEMBL30234609
- BDBM85026
- KVCSJPATKXABRQ-UHFFFAOYSA-N
- C22H31N3O2
- BCP15982
- EX-A1189
- ZINC1537633
- CID177336
- PDSP1_001702
- PDSP2_001685
- Serotonin 5 HT4 Receptor Antagonists
- AKOS015909931
- C22-H31-N3-O2
- CID:177336
- CS-4311
- DB04873
- FD10684
- N-[(1-butylpiperidin-4-yl)methyl]-3,4-dihydro-2H-[1,3]oxazino[3,2-a]indole-10-carboxamide
- SB 207266
- SB 207266-A
- NCGC00250378-01
- AC-36094
- AS-82492
- BP166459
- HY-15574
- thiazolo[3,2-a]indole-9-carboxylic acid
- N-((1-butylpiperidin-4-yl)methyl)-3,4-dihydro-2H-[1,3]oxazino[3,2-a]indole-10-carboxamide
- SID:134223294
- J711.350A
- SB 207256
- FT-0722955
- NS00068599
- A15542
- Q75884
- SB-207266, >=98% (HPLC)
- A980013
- D058832
- L000973
- PIBOSEROD,2H-(1,3)OXAZINO(3,2-A)INDOLE-10-CARBOXAMIDE, N-((1-BUTYL-4-PIPERIDINYL)METHYL)-3,4-DIHYDRO-
- BRD-K02750403-001-01-4
- BRD-K02750403-001-02-2
- I14-31853
- N-[(1-BUTYLPIPERIDIN-4-YL)METHYL]-2H,3H,4H-[1,3]OXAZINO[3,2-A]INDOLE-10-CARBOXAMIDE
- N-(1-Butylpiperidine-4-ylmethyl)-1,2-(trimethyleneoxy)-1H-indole-3-carboxamide
- N-[(1-butyl-4-piperidinyl)methyl]-3,4-dihydro-2H-[1,3]-oxazino[3,2-a]indole-10-carboxamide
- N-((1-butylpiperidin-4-yl)methyl)-2H,3H,4H-(1,3)oxazino(3,2-a)indole-10-carboxamide
- N-[(1-butyl-4-piperidyl)methyl]-3,4-dihydro-2H-[1,3]oxazino[3,2-a]indole-10-carboxamide
- 110-127-4
- 152812-49-2
- 290815-26-8
- 2H-(1,3)OXAZINO(3,2-A)INDOLE-10-CARBOXAMIDE, N-((1-BUTYL-4-PIPERIDINYL)METHYL)-3,4-DIHYDRO-
- 2H-[1,3]oxazino[3,2-a]indole-10-carboxamide, N-[(1-butyl-4-piperidinyl)methyl]-3,4-dihydro-
- 3,4-Dihydro-N-[(1-butyl-4-piperidinyl)methyl]-2H-[1,3]oxazino[3,2-a]indole-10-carboxamide
- N-((1-Butyl-4-piperidyl)-methyl)-3,4-dihydro-2H-(1,3)oxazino(3,2-a)indole-10-carboxamide
- N-((1-BUTYL-4-PIPERIDYL)METHYL)-3,4-DIHYDRO-2H-(1,3)OXAZINO(3,2-A)INDOLE-10-CARBOXAMIDE
- N-((1-butylpiperidin-4-yl)methyl)-3,4-dihydro-2H-(1,3)oxazino(3,2-a)indole-10-carboxamide
- N-[(1-Butyl-4-piperidinyl)methyl]-3,4-dihydro-2H-[1,3]-oxazino[3,2-alpha]indole-10-carboxamide
- N-[(1-Butyl-4-piperidinyl)methyl]-3,4-dihydro-2H-[1,3]oxazino[3,2-a]indole-10-carboxamide
- N-[(1-Butyl4-piperidinyl)methyl]-3,4-dihydro-2H-[1,3]-oxazino[3,2-a]indole-10-carboxamide
- N-[(1-butylpiperidin-4-yl)methyl]-3,4-dihydro-2H-[1,3]oxazino[3,2-a]indole-10-carboxamide<br/>Piboserod<br/>UNII-4UQ3S81B25<br/>SB-207266<br/>152811-62-6<br/>SB207256<br/>SB 207266<br/>N-[(1-butylpiperidin-4-yl)methyl]-3,4-dihydro-2H-[1,3]oxazino[3,2-a]indole-10-carboxamide<br/>Pibosero